Wilson Sonsini Goodrich & Rosati advised Enlaza on IP matters related to the transaction. Enlaza Therapeutics (Enlaza), the first covalent biologic platform company, announced it closed...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
